Neutrophil Gelatinase-associated Lipocalin in the Prediction of Contrast-induced Nephropathy: A Systemic Review and Meta-analysis

Journal of Cardiovascular Pharmacology

Volumn 66, Issue 3, 2015, Pages 239-245

  Tong, Junrong ^a   Li, Hong ^b   Zhang, Hong ^a   Luo, Zhengmao ^a   Huang, Yuanhang ^a   Huang, Jun ^c   He, Feng ^a,c   Fu, Junzhou ^c  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b Guangdong Province Pharmaceutical Association   (China)

^c GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

contrast induced nephropathy; meta analysis; neutrophil gelatinase associated lipocalin

Indexed keywords

BIOLOGICAL MARKER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACUTE PHASE PROTEIN; CONTRAST MEDIUM; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

CONFIDENCE INTERVAL; CONTRAST INDUCED NEPHROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ACUTE KIDNEY INJURY; BLOOD; CHEMICALLY INDUCED; PREDICTIVE VALUE; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOMARKERS; CONTRAST MEDIA; EARLY DIAGNOSIS; HUMANS; LIPOCALINS; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS;

EID: 84942067715     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000268     Document Type: Review

References (31)

1. Katzberg RW, Haller C. Contrast-induced nephrotoxicity: clinical landscape. Kidney Int Suppl. 2006;16(suppl 100):S3-S7.
2. Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol. 2005;28(suppl 2):S3-S11.
3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930-936.
4. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259-2264.
5. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419-1428.
6. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354:379-386.
7. Stacul F, Adam A, Becker CR, et al; CIN Consensus Working Panel. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol. 2006;98:59K-77K.
8. Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol. 2007;156:203-212.
9. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534-2543.
10. Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore- iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005;115:610-621.
11. Supavekin S, Zhang W, Kucherlapati R, et al. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003;63:1714-1724.
12. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine? Int J Cardiol. 2008;127:290-291.
13. Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;54:1012-1024.
14. Peacock WF IV, Maisel A, Kim J, et al. Neutrophil gelatinase associated lipocalin in acute kidney injury. Postgrad Med. 2013;125:82-93.
15. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUA-DAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25.
16. Harbord RM, Deeks JJ, Egger M, et al. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics. 2007;8:239-251.
17. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta- analyses. BMJ. 2003;327:557-560.
18. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58:882-893.
19. Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007;22:2089-2095.
20. Ling W, Zhaohui N, Ben H, et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract. 2008;108:c176-181.
21. Liu XL, Wang ZJ, Yang Q, et al. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention. Chin Med J (Engl). 2012;125:1051-1056.
22. Luo Q, Zhou F, Dong H, et al. Implication of combined urinary biomarkers in early diagnosis of acute kidney injury following percutaneous coronary intervention. Clin Nephrol. 2013;79:85-92.
23. Valette X, Savary B, Nowoczyn M, et al. Accuracy of plasma neutrophil gelatinase-associated lipocalin in the early diagnosis of contrast-induced acute kidney injury in critical illness. Intensive Care Med. 2013;39:857-865.
24. Lacquaniti A, Buemi F, Lupica R, et al. Can neutrophil gelatinase-associated lipocalin help depict early contrast material-induced nephropathy? Radiology. 2013;267:86-93.
25. Alharazy SM, Kong N, Saidin R, et al. Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography. Angiology. 2013;65:216-223.
26. Tasanarong A, Hutayanon P, Piyayotai D. Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. BMC Nephrol. 2013;14:270-282.
27. Liebetrau C, Gaede L, Doerr O, et al. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention. Scand J Clin Lab Invest. 2014;74:81-88.
28. Padhy M, Kaushik S, Girish MP, et al. Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Clin Chim Acta. 2014;435:48-52.
29. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens. 2008;17:127-132.
30. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393-1399.
31. Clerico A, Galli C, Fortunato A, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences. Clin Chem Lab Med. 2012;50:1505-1517.